Down-regulation of TRIB3 inhibits the progression of ovarian cancer via MEK/ERK signaling pathway.
Shuang WangCaixia WangXiao LiYuexin HuRui GouQian GuoXin NieJuanjuan LiuLiancheng ZhuBei LinPublished in: Cancer cell international (2020)
The TRIB3 was highly expressed and promoting the malignant behavior of ovarian cancer cells by activating the MEK-ERK signaling pathway. It was also found to be associated with genetic variations and immune modulators.